Stay updated on Risankizumab in Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in Psoriatic Arthritis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4, signaling a newer version of the page's documentation for the study record (likely updates to linked documents or notices, not changes to study results).
    Difference
    0.0%
    Check dated 2026-05-14T22:54:22.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The Study Documents section shows Revision: v3.5.3, replacing Revision: v3.5.2. This indicates an updated version of the documents provided by AbbVie.
    Difference
    0.0%
    Check dated 2026-04-30T16:25:44.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-16T09:38:00.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; no visible changes to the study details or page features.
    Difference
    0.0%
    Check dated 2026-03-25T20:07:05.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now shown on the page, replacing the previous v3.4.2 label.
    Difference
    0.0%
    Check dated 2026-03-11T14:57:47.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The government funding notice and Revision: v3.4.1 were removed.
    Difference
    0.2%
    Check dated 2026-02-11T09:53:42.000Z thumbnail image

Stay in the know with updates to Risankizumab in Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.